About Coyote Bioscience
Coyote Bioscience is a company based in Beijing (China) founded in 2012. Coyote Bioscience operates in a competitive market with competitors including Cepheid, Fluidigm, Complete Genomics, GenapSys and Stilla Technologies, among others.
- Headquarter Beijing, China
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website coyotebio.com
- Social LinkedIn
- InvestorsHillhouse
& 7 more
Funding Insights of Coyote Bioscience
- Total Rounds 5
- Investors Count 8
All 5 funding rounds of Coyote Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2020 | – | Series D | – | Hillhouse | |
| Mar 2019 | – | Series C | – | Longly Capital, Jilin Investment Group | – |
| Apr 2018 | – | Series C | – | Longly Capital, Frees Fund | – |
| Sep 2017 | – | Series C | – | New Equation Investment | – |
| Jan 2016 | – | Series B | – | Northern Light Venture Capital |
8 investors in total: 8 institutional.
Investors in Coyote Bioscience
Coyote Bioscience has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Hillhouse, Frees Fund and Longly Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global private equity investments are managed with long-term focus. | – | hillhouseinvestment.com | New York, United States | |
Tech focused VC firm investing in early stage companies in the US & China | – | freesvc.com | Beijing, China | |
- | – | longlycapital.com | - | |
- | – | jlic.net.cn | - | |
Chinese startups are funded and incubated by Legend Star. | – | legendstar.com.cn | Beijing, China | |
Provider of early stage venture capital focused on technology companies | – | nlvc.com | Menlo Park, United States | |
A leading private equity firm supporting high-growth enterprises in Asia. | – | saifpartners.com.cn | Chaoyang, China | |
Provides private equity investment fund management services. | 2010 | xinfangcheng.com | Shanghai, China |
Investor details for Coyote Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Coyote Bioscience
4 people are tracked at Coyote Bioscience (2 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Yuxing Liu | Human Resources Business Partner | Leadership |
Sabrina Li | CEO And Founder | Leadership |
Israel Rivera Martinez | Business Development Manager / FAS Latam | Team |
Gabor Płoszay | Business Development Manager - CEE & CIS | Team |
Complete people profiles for Coyote Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Coyote Bioscience
3 dated milestones of Coyote Bioscience across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Coyote Bioscience is founded.
- Funding First funding round.
- Funding Latest funding round, Series D,.
Competitors of Coyote Bioscience
Coyote Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Fluidigm, Complete Genomics, GenapSys and Stilla Technologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cepheid.com | 1996 | Sunnyvale, United States | $19.1M | 1,299 | Developer of molecular diagnostic testing solutions | |
| fluidigm.com | 1999 | San Francisco, United States | $40.53M | 205 | Instruments for life sciences research and applications are developed. | |
| completegenomics.com | 2006 | San Jose, United States | $124.99M | 70 | DNA sequencing platform for human genome analysis is developed. | |
| genapsys.com | 2010 | Redwood, United States | $313.03M | 60 | Provider of DNA sequencing technologies for applied genomic testing and medical sequencing | |
| stillatechnologies.com | 2013 | Villejuif, France | $53.11M | – | Digital PCR solutions for research are developed and analyzed. | |
| stratosgenomics.com | 2007 | Seattle, United States | $62.89M | 64 | Nanopore-based single molecule sequencers are developed using SBX technology. | |
| nabsys.com | 2004 | Providence, United States | $144.3M | 44 | Developer of tools to map whole genome sequencing | |
| quantalife.com | 2008 | Pleasanton, United States | $28.71M | – | Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease. | |
| iontorrent.com | 2007 | Guilford, United States | $37.06M | – | Next-generation sequencing is enabled by semiconductor technology for DNA analysis. | |
| helixis.com | 2007 | Carlsbad, United States | $17.33M | – | Nucleic-acid analysis instruments were developed for research and clinical applications. |
Detailed competitors of Coyote Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Coyote Bioscience
The website of Coyote Bioscience (coyotebio.com) receives about 1.5K visits a month and ranks #9,574,779 among all websites worldwide, #7,719 in Biotechnology and Pharmaceuticals.
- Monthly visits1.5K
▼ 2.5% vs previous month
- Global rank#9,574,779
among all websites
- Category rank#7,719
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit1.9
- Average visit50 sec
- DevicesDesktop 29% · Mobile 71%
Websites whose visitors overlap most with Coyote Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pilotgene.com | 100% | – | – | View details |
Latest news on Coyote Bioscience
Complete news archive for Coyote Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Coyote Bioscience
10 companies that operate in the same segment as Coyote Bioscience (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Coyote Bioscience
Coyote Bioscience was founded in 2012 and raised its 1st funding round 4 years after it was founded.
Coyote Bioscience is headquartered in Beijing, China.
Coyote Bioscience develops and markets PCR instrumentation and reagents. It has two instruments. The Mini8 Plus Real-Time PCR System has a small footprint and is optimized for life science research. The One-Step MD-Box-Lab is a portable nucleic acid detection system with applications in clinical diagnostics. The company has also developed qPCR kits for the detection of drug resistant bacteria, viral infectious strains and cancer screening.
Coyote Bioscience's top competitors include Cepheid, Stilla Technologies and Complete Genomics.
Coyote Bioscience has 8 investors. Key investors include Hillhouse, Frees Fund, Longly Capital, Jilin Investment Group, and New Equation Investment.